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ABSTRACT
Objective: The main objective of the study is to synthesis some novel pyrimidine scaffold which has wide range of properties of biological activities.
Methods: Synthesis of different pyrazole derivatives compounds identification and characterization (M.P, solubility, Rf values, and spectral studies). 
The present work was characterized by infrared, nuclear magnetic resonance, and mass spectral analysis pharmacological evaluation.
Results: Identification and characterization (M.P, solubility, Rf values and spectral studies) are carried out.
Keywords: M.P, Solubility, Rf values, Spectral studies.
INTRODUCTION
Pyrazole derivatives play an important role in the “field of medicinal 
chemistry due to a wide range of biological” outcomes “exhibited by 
them” [1]. The uses “of” pyrazole derivatives in clinical medicines are 
well documented, due to their potent therapeutic values in NSAID, 
central nervous system, and microbial diseases [2,3]. “Pyrazole refers to 
the class of simple aromatic ring organic compounds of the heterocyclic” 
compounds “characterized by a five-membered ring structure 
composed of” two nitrogen “atoms” in adjacent positions with three 
carbon atoms “and to the unsubstituted parent compound” [4]. They are 
“so composed and having pharmacological effects, they are classified 
as alkaloids,” though the availability is very rare in nature. Heterocyclic 
compounds play an important role in medicinal chemistry for health-
care system. Most frequently encountered heterocyclic molecule 
in medicinal chemistry is quinazolinone and pyrazole having wide 
application [5]. Pyrazole derivatives are with good “diverse biological 
activities such as” analgesic, “antihyperglycemic,” antipyretic, “anti-
inflammatory, sedative-hypnotic activity, cyclooxygenase-2 (Cox-2) 
inhibitors, interleukin-1 synthesis inhibitors,” and antibacterial. 
Pyrazole was first defined by “LUDWIG KNORR” “in 1883” [6]. “The 
simple unsaturated compound containing two nitrogen and three 
carbon atoms in the ring, with the nitrogen atoms” in adjacent 
positions, “is known as pyrazole.” Pyrazoline and pyrazolidine are 
the reduction products, with five atoms as a ring structure. Several 
pyrazoline derivatives are used in medicine. Many of the medicinal 
derivatives are with 5-pyrazolone and 3,5-pyrazolidindione. “Pyrazole 
is a colorless solid” and “melting point 70°C” [7]. This “high value” “is 
due to intermolecular hydrogen bonding which results in a” dimmer. 
“Pyrazole” exists as “a tautomeric substance” which “cannot be 
demonstrated in pyrazole itself, but it can be inferred by the pyrazole 
derivatives.” Pyrazoline derivatives occupy a major role in “medicinal 
chemistry due to a wide range of biological activities exhibited by 
them” “Cox, also known as prostaglandin H (PGH) synthase, is a key 
enzyme involved in the biosynthetic cascade of prostanoids that result 
in the formation of prostaglandins, prostacyclins, and thromboxanes 
from polyunsaturated fatty acid.” “Cox catalyzes the conversion of 
arachidonic acid into an intermediate PGH2, a precursor of variety of 
biologically important prostanoids” [8-10].
EXPERIMENTAL
Step-I: Ethoxymethylene malononitrile
Malononitrile (5.2 g, 80 mmol), triethyl orthoformate (13.2 ml, 80 mmol), 
and acetic anhydride (20.0 ml, 20 mmol) were taken in a round bottom 
flask fitted with a reflux condenser and calcium guard tube and refluxed 
for 12 h at 110°C. The excess acetic anhydride was distilled off from the 
reaction medium under negative pressure and the residue was added 
to ice. The precipitate (1) was washed with cold water, then filtered off, 
air dried, and crystallized from chloroform. The compound formation 
was confirmed with thin-layer chromatography (TLC) chloroform:ethyl 
acetate (7:3) with Rf value 0.72 with an yield of 64.75%, melting point 
57°C, mol. formula C6H6N2O, and mol. weight 212.12.
Step-II: 5-amino-4-cyano-1-phenyl pyrazole
Ethoxymethylene malononitrile (1) (5.0 g, 40 mmol), phenylhydrazine 
(4.0 ml, 40 mmol), and ethanol (20.0 ml) were taken in a round bottom 
flask and heated to reflux for 2 h at 80°C. The excess ethanol was distilled off 
from the reaction medium and the residue was added to ice. The precipitate 
(2) was washed with cold water, then filtered off, air dried, and crystallized 
from chloroform. The compound formation was confirmed with TLC 
chloroform:ethyl acetate (7:3) with Rf value 0.54 with an yield of 77.02%, 
melting point 140°C, mol. formula C10H8N4, and mol. weight 184.19.
Step-III: “5-amino-1-phenyl pyrazole-4-carboxamide”
To concentrated sulfuric acid (40.0 ml) in a 1.0 L beaker, small quantity 
“of 5-amino-4-cyano-1-phenyl pyrazole” (2) (7.5 g, 40 mmol) was added 
with continuous stirring for 2 h. It was then neutralized with dil. sodium 
hydroxide solution, to PH 7, under ice-cold condition. “The resulting 
precipitate” (3) “was filtered off, dried, and crystallized from” chloroform. 
The compound formation was confirmed with TLC chloroform:ethyl 
acetate (7:3) with Rf value 0.66 with an yield of 99.64%, melting point 
170°C, mol. formula C10H10N4O, and mol. weight 202.29.
EVALUATION OF PHARMACOLOGICAL ACTIVITY
Evaluation of anti-inflammatory activity
“The lead compounds are screened for anti-inflammatory activity using” 
the technique “inhibition of albumin denaturation” as per Muzushima 
and Kabayashi with slight modification as given in Scheme 1.
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EVALUATION OF ANTIOXIDANT ACTIVITY
Free radicals are reactive atoms that have one or more unpaired 
electrons, especially one that is produced in the humans as natural 
biological processes or produced from outside (as in toxins or 
pollutants and tobacco smoke) “and that can damage cells proteins 
and DNA by altering their chemical” nature. Free radicals are generally 
considered as a part of molecules and which are short valid and 
extremely “reactive.” “They are produced” spontaneous “in cells 
either as accidental by-products of metabolism or deliberately” by 
“phagocytosis.” “Free radicals can be formed in three methods: (1) 
Hemolytic cleavage of a covalent bond of a normal molecule, each 
fragment” retains “one of the paired electrons,” (2) addition “of a 
single” from “a normal molecule.” and “(3) addition of a single electron 
to molecule.” Later, “electron transfer is a common process in biological 
systems.” The “important free radicals in biological” functions “are 
radical” derivative “of oxygen.” “The” free radical process is a lipid 
peroxidation plays a radical and causative role in the pathogenesis 
of cancer, atherosclerosis, and myocardial infarction. Free radical 
oxidative interactions promote tissue injury in conditions such as 
toxicity, brain trauma, and ischemia and also in neurodegenerative 
diseases such as Alzheimer’s, dementia, Parkinsonison’s disease, and 
multiple sclerosis are now well documented. “Highly reactive free 
radicals and oxygen species are present in biological systems from a 
wide variety of sources.” “These free radicals may oxidize” proteins, 
“nucleic acids,” DNA, or “lipids and can initiate degenerative disease.” 
“Antioxidant compounds such as” flavonoids and “polyphenols” 
which “scavenge free radicals such as peroxide,” hydrogen peroxide, 
or “lipid peroxyl and thus inhibit the oxidative mechanisms that lead 
to degenerative diseases.” “There are a number of clinical studies, 
suggesting that the antioxidants in fruits, vegetables, tea, and red 
wine are the main factors for the observed efficacy of these foods in 
reducing the incidence of chronic diseases including heart disease and 
some cancers.”
ANTIFUNGAL ACTIVITY
“The” antifungal “activity” of the lead molecules was performed by disc 
diffusion method which was compared with standard drug fluconazole. 
It is orally active broad-spectrum antifungal agent.
CONCLUSION
The present study developed a simple, inexpensive, and facile method for 
synthesis of pyrazole derivatives in a short duration in mild conditions. 
All pyrazole derivatives yielded a good outcome of in the range of 60–
94%. The purity of the compounds was ascertained by a TLC and melting 
point. The lead structure was further established by infrared,1H nuclear 
magnetic resonance, and MS spectral studies. “Using inhibition of albumin 
denaturation technique which was studied according to Muzushima and 
Kabayashi with slight modification the” acute “and” chronic studies for 
anti-inflammatory activity of the synthesized compounds was screened. 
In the prepared pyrazole derivatives, it seemed that the compounds 
ethoxymethylene malononitrile, “5-amino-4-cyano-1-phenyl pyrazole,” 
and 5-amino-1-phenyl pyrazole-4-carboxamide showed potent activity. 
From the above study, it can be concluded that the pyrazole derivatives 
are potentially be developed into useful anti0inflammatory agents, 
which lead to further optimization for producing a novel heterocyclic 
system, with potent activity.
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